Default company panoramic image
82651af2 3b5f 4b8c b383 3c154a8834ff

Oryx Bio, Inc.

Oryx Bio provides faster, less costly, more efficient ways for researchers and manufacturers to separate and purify biological mixtures.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Raleigh, NC, USA
  • Currency USD
  • Founded January 2012
  • Employees 2
  • Website oryxbio.com

Company Summary

Oryx Bio integrates new and novel patented affinty peptides with both traditional resin based filtration and newer, less costly, high performance nonwoven nano fabrics drastically reducing the costs associated with separating and purifying protein therapeutics and other complex biological mixtures while increasing the yield and quality. Researchers and Pharma companies and related institutions are our global customers.

Team

  • Default avatar
    Joseph Louis Magno
    CEO

    He has successfully founded, grown and sold a number of technology based enterprises and has held leadership positions in private industry, government and academia. Experience includes leading startup companies as well as orchestrating multi-billion dollar public-private nano and biotech initiatives in both government and academic settings. Currently living in North Carolina

  • Default avatar
    Ruben G. Carbonell
    Chief Scientific Officer

    Dr. Carbonell is a globally recognized expert in the isolation and purification of biological molecules and biomanufacturing. He is the Director of the Golden LEAF Biomanufacturing Training and Education Center (BTEC) at NCSU, as well as the Frank Hawkins Kenan Distinguished Professor and the Director of the William R. Kenan, Jr. Institute for Engineering, Technology and Science.

  • Default avatar
    AJ Colletti
    Chief Operating Officer

    Mr. Colletti is the Principal of PhoenixGroup, an international consulting firm serving international governments, private sector businesses, and investors; among current projects, he serves as technical operations advisor to senior international government officials. Mr. Colletti has been directly responsible for the development, design and delivery of over $6 billion in medical, research and biotechnology facilities worldwide.

  • Default avatar
    Laban Coblentz
    Secretary

    Mr. Coblentz brings expertise in communications, diplomacy, and applied science and engineering. As an executive at Rensselaer Polytechnic Institute, he gained recognition for innovative entrepreneurship and IP commercialization ventures. He came to RPI from the International Atomic Energy Agency, where he engaged in nuclear diplomacy in Iraq, Iran, and other settings and worked to set up tech transfer enterprises in developing countries.

Advisors

  • Default avatar
    David Otterson
    Lawyer
    Unconfirmed
    Default avatar
    Max Koss
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    NC State University
    Unconfirmed
    Default avatar
    Millipore (research grants)
    Unconfirmed
    Default avatar
    North Carolina Biotech Center
    Unconfirmed